Cookies on Pinsent Masons website

This website uses cookies to allow us to see how the site is used. The cookies cannot identify you. If you continue to use this site we will assume that you are happy with this

If you want to use the sites without cookies or would like to know more, you can do that here.

Patent holder rights to bar parallel imports of their drugs from EU accession states not automatic, CJEU advisor says

Pharmaceutical companies should not be allowed to prevent drugs they put onto market in an EU accession state from being imported into a more established EU country where they hold patent rights for those medicines unless they signal their intention to rely... 24 Oct 2014

AbbVie: "risks and uncertainty" of US tax policy behind decision to drop Shire bid

US pharmaceutical company AbbVie dropped its proposed £54 billion acquisition of UK rival Shire as a direct result of changes to the way in which authorities in the US treat cross-border mergers for corporate tax purposes, it has confirmed. 21 Oct 2014

Out-Law Guides

More guides

EMA to investigate reports that software issue may have affected accuracy of clinical trials

The European Medicines Agency (EMA) has confirmed that it is looking into recent reports that a widely-used clinical data software package may have introduced inaccuracies into clinical trials, according to Reuters. 16 Oct 2014

London Health Commission recommendations on healthcare delivery could be "revolutionary", says expert

A new approach to healthcare delivery based on patient need, a £1 billion programme to refurbish and extend the opening hours of doctors' surgeries and a new London-based 'Centre for Digital Health' are among the main recommendations of a new report on the... 15 Oct 2014

More stories